Analyst Update: Celgene Corporation, Geron Corporation, and NeoPhotonics Corp

Analysts are weighing in on Celgene Corporation (NASDAQ:CELG), Geron Corporation (NASDAQ:GERN), and NeoPhotonics Corp (NYSE:NPTN)

Sep 12, 2016 at 3:25 PM
facebook X logo linkedin


Analysts are weighing in on biotech stocks Celgene Corporation (NASDAQ:CELG), and Geron Corporation (NASDAQ:GERN), as well as optical communications specialist NeoPhotonics Corp (NYSE:NPTN). Here's a quick roundup of today's brokerage notes on CELG, GERN, and NPTN.

  • CELG is just one of many biotechs on the move, currently sitting up 1.9% at $106.49, after announcing promising data on its Crohn's treatment. While Baird maintained an "outperform" endorsement and $162 price target, the analyst said CELG's "big 2H16 catalyst turned out to be a non-event," and wondered why there wasn't more data delivered. The biotech is down 11.1% so far this year, and recently filled in its late-July bull gap, but seems to have found a foothold atop its 160-day moving average. The security's 10-day put/call volume ratio at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) of 0.58 sits in the 75th percentile of its annual range, suggesting CELG put buying has been more active than usual.

  • GERN is the worst performer on the New York Stock Exchange (NYSE), currently down 19.9% at $2.29 -- and just off its lowest point since October 2014. Partner Johnson & Johnson's (NYSE:JNJ) drug-testing arm, Janssen, announced that it won't continue trials of a low dosage of GERN's blood cancer treatment, imetalstat, although Janssen will continue to pursue trials of higher dosages. The biotech was hit with a pair of price-target cuts by Piper Jaffray and Janney -- both to $5, from $10 and $6.50, respectively. Today's plunge puts the stock down over 52% since the beginning of 2016. Option bears and short sellers alike are probably cheering today's fall; GERN's 10-day ISE/CBOE/PHLX put/call volume ratio of 3.04 sits just 2 percentage away from an annual high, and a lofty 17.8% of GERN's float is sold short, which would take over four weeks of trading to cover, at GERN's average daily volume. Today, however, GERN is on the short-sale restricted list.

  • NPTN is up 6.7% at $17.63 -- earlier touching a new five-year high of $18 -- after Needham raised its price target to $22 from $20, citing a strong potential upside for the stock based on China purchase orders. The optical communications specialist has more than doubled since June, drawing support from its 10- and 20-day moving averages. As such, option bulls have been hot on the stock, with 27.34 calls bought to open for every put over the last 10 days at the ISE/CBOE/PHLX.
Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI